
Congress trades
Acadia Healthcare Company, Inc. (ACHC)
NASDAQ · Healthcare · 9 congress trades · last filed 4 years ago
About Acadia Healthcare Company, Inc.
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Chief executive
- Debra K. Osteen
- Employees
- 25,000
- Listed since
- Mar 4, 1994
- Market value
- $2.6B
- Price to earnings
- -
- Earnings per share
- -$12.40
- Dividend yield
- -
Earnings
6 reported quarters · next on Nov 4, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 28, 2026 | $0.38 | $0.35 | $865.8M | $844.2M | EPS beatRevenue beat |
| Q1 FY2026reported Apr 29, 2026 | $0.37 | $0.28 | $828.8M | $823.5M | EPS beatRevenue in line |
| Q4 FY2025reported Feb 25, 2026 | $0.07 | $0.03 | $821.5M | $800.1M | EPS beatRevenue beat |
| Q3 FY2025reported Nov 5, 2025 | $0.72 | $0.68 | $851.6M | $848.5M | EPS beatRevenue in line |
| Q2 FY2025reported Aug 5, 2025 | $0.83 | $0.71 | $869.2M | $875.5M | EPS beatRevenue in line |
| Q1 FY2025reported May 12, 2025 | $0.40 | $0.35 | $770.5M | $769.8M | EPS beatRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Mar 25, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Brian P. FarleyExecutive Vice President, General Counsel and Secretar | $609K | $1.8M | $455K | $2.8M |
| Todd S. YoungChief Financial Officer | $98K | $1.1M | $0 | $1.2M |
The summary compensation table from the 2025 proxy statement, current executives only. 4 executives who have since left the company are named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $441.7M | 14,957,168 | +28.0% | 16.47% |
| Wellington Management Group LLP | $169.1M | 5,726,246 | -36.9% | 6.31% |
| Vanguard Portfolio Management LLC | $158.6M | 5,369,461 | +6.1% | 5.91% |
| FMR LLC | $148.1M | 5,015,727 | -27.0% | 5.52% |
| Carronade Capital Management, LP | $140.6M | 4,762,635 | +103.8% | 5.24% |
| Morgan Stanley | $133.9M | 4,534,269 | +1.0% | 4.99% |
| Deerfield Management Company, L.P. (Series C) | $133.5M | 4,520,000 | 0.0% | 4.98% |
| DME Capital Management, LP | $130.0M | 4,400,641 | -2.6% | 4.85% |
| Farallon Capital Management LLC | $124.6M | 4,220,800 | +143.0% | 4.65% |
| Abrams Bison Investments, LLC | $123.0M | 4,165,000 | -4.9% | 4.59% |
| UBS Group AG | $119.4M | 4,044,500 | +42.7% | 4.45% |
| Dimensional Fund Advisors LP | $118.5M | 4,013,718 | +55.5% | 4.42% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
Congress trades in ACHC
9 disclosures of 9 on record · median 17d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Susie LeeJoint | Stock | Sale | $1,001 - $15,000 | -68.2%S&P +87.5% · vs S&P 500 -155.7% | Nov 30, 2022 | Dec 29, 2022 | 29d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +0.2%S&P +165.4% · vs S&P 500 -165.2% | Aug 12, 2019 | Sep 11, 2019 | 30d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -4.5%S&P +172.0% · vs S&P 500 -176.5% | Mar 26, 2019 | Apr 11, 2019 | 16d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -8.8%S&P +193.7% · vs S&P 500 -202.5% | Nov 27, 2017 | Dec 12, 2017 | 15d |
| Michael T. McCaul | Stock | Sale | $50,001 - $100,000 | -46.7%S&P +285.9% · vs S&P 500 -332.6% | Oct 28, 2014 | Nov 14, 2014 | 17d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | -39.0%S&P +293.2% · vs S&P 500 -332.2% | Jun 17, 2014 | Jul 15, 2014 | 28d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | -33.6%S&P +297.6% · vs S&P 500 -331.2% | May 30, 2014 | Jun 10, 2014 | 11d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | -37.7%S&P +314.2% · vs S&P 500 -351.9% | Mar 26, 2014 | Apr 10, 2014 | 15d |
| Michael T. McCaul | Stock | Purchase | $15,001 - $50,000 | -40.6%S&P +308.2% · vs S&P 500 -348.8% | Mar 20, 2014 | Apr 10, 2014 | 21d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 9, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded ACHC?
Susie Lee, Ro Khanna, Michael T. McCaul disclosed ACHC transactions in the filings shown here.
How quickly are ACHC trades disclosed?
Congressional disclosures took a median of 17 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.
